Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1972 Apr;67(1):181–210.

Participation of components of the blood coagulation system in the inflammatory response.

D G McKay
PMCID: PMC2032589  PMID: 4261590

Full text

PDF
186

Images in this article

205Fig 1
on p.205
206Fig 2
on p.206
207Fig 3
on p.207
208Fig 4
on p.208
209Fig 5
on p.209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLISON F., Jr, LANCASTER M. G., CROSTHWAITE J. L. STUDIES ON THE PATHOGENESIS OF ACUTE INFLAMMATION. V. AN ASSESSMENT OF FACTORS THAT INFLUENCE IN VITRO THE PHAGOCYTIC AND ADHESIVE PROPERTIES OF LEUKOCYTES OBTAINED FROM RABBIT PERITONEAL EXUDATE. Am J Pathol. 1963 Nov;43:775–795. [PMC free article] [PubMed] [Google Scholar]
  2. Aronson S. B., Elliott J. H., Moore T. E., Jr, O'Day D. M. Pathogenetic approach to therapy of peripheral corneal inflammatory disease. Am J Ophthalmol. 1970 Jul;70(1):65–90. doi: 10.1016/0002-9394(70)90670-7. [DOI] [PubMed] [Google Scholar]
  3. BLOOM G., GUSTAVSON K. H., SWENSSON A. On the reaction of the thrombocytes to submicroscopic particles in vitro. Acta Haematol. 1955 Jan;13(1):57–63. doi: 10.1159/000204923. [DOI] [PubMed] [Google Scholar]
  4. Breckenridge R. T., Ratnoff O. D. The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide. J Clin Invest. 1965 Feb;44(2):302–314. doi: 10.1172/JCI105144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CHRISTIAN C. L. Studies of aggregated gamma-globulin. II. Effect in vivo. J Immunol. 1960 Jan;84:117–121. [PubMed] [Google Scholar]
  6. COCHRANE C. G., UNANUE E. R., DIXON F. J. A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS. J Exp Med. 1965 Jul 1;122:99–116. doi: 10.1084/jem.122.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DAVIE E. W., RATNOFF O. D. WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. Science. 1964 Sep 18;145(3638):1310–1312. doi: 10.1126/science.145.3638.1310. [DOI] [PubMed] [Google Scholar]
  8. DINIZ C. R., CARVALHO I. F. A micromethod for determination of bradykininogen under several conditions. Ann N Y Acad Sci. 1963 Feb 4;104:77–89. doi: 10.1111/j.1749-6632.1963.tb17654.x. [DOI] [PubMed] [Google Scholar]
  9. DONALDSON V. H., EVANS R. R. A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. Am J Med. 1963 Jul;35:37–44. doi: 10.1016/0002-9343(63)90162-1. [DOI] [PubMed] [Google Scholar]
  10. Des Prez R. M., Bryant R. E. Effects of bacterial endotoxin on rabbit platelets. IV. The divalent ion requirements of endotoxin-induced and immunologically induced platelet injury. J Exp Med. 1966 Nov 1;124(5):971–982. doi: 10.1084/jem.124.5.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Donaldson V. H. Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro. J Exp Med. 1968 Mar 1;127(3):411–429. doi: 10.1084/jem.127.3.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Evans G., Mustard J. F. Platelet-surface reaction and thrombosis. Surgery. 1968 Jul;64(1):273–280. [PubMed] [Google Scholar]
  13. GRAHAM R. C., Jr, EBERT R. H., RATNOFF O. D., MOSES J. M. PATHOGENESIS OF INFLAMMATION. II. IN VIVO OBSERVATIONS OF THE INFLAMMATORY EFFECTS OF ACTIVATED HAGEMAN FACTOR AND BRADYKININ. J Exp Med. 1965 May 1;121:807–818. doi: 10.1084/jem.121.5.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. HALPERN B., MILLIEZ P., LAGRUE G., FRAY A., MORARD J. C. PROTECTIVE ACTION OF HEPARIN IN EXPERIMENTAL IMMUNE NEPHRITIS. Nature. 1965 Jan 16;205:257–259. doi: 10.1038/205257a0. [DOI] [PubMed] [Google Scholar]
  15. HUMPHREY J. H. The mechanism of Arthus reactions. II. The role of polymorphonuclear leucocytes and platelets in reversed passive reactions in the guinea-pig. Br J Exp Pathol. 1955 Jun;36(3):283–289. [PMC free article] [PubMed] [Google Scholar]
  16. HURLEY J. V. SUBSTANCES PROMOTING LEUKOCYTE EMIGRATION. Ann N Y Acad Sci. 1964 Aug 27;116:918–935. doi: 10.1111/j.1749-6632.1964.tb52558.x. [DOI] [PubMed] [Google Scholar]
  17. JANCSO N. Inflammation and the inflammatory mechanisms. J Pharm Pharmacol. 1961 Oct;13:577–594. doi: 10.1111/j.2042-7158.1961.tb11873.x. [DOI] [PubMed] [Google Scholar]
  18. KELLERMEYER R. W., BRECKENRIDGE R. T. THE INFLAMMATORY PROCESS IN ACUTE GOUTY ARTHRITIS. I. ACTIVATION OF HAGEMAN FACTOR BY SODIUM URATE CRYSTALS. J Lab Clin Med. 1965 Feb;65:307–315. [PubMed] [Google Scholar]
  19. KLEINERMAN J. Effects of heparin on experimental nephritis in rabbits. Lab Invest. 1954 Nov-Dec;3(6):495–508. [PubMed] [Google Scholar]
  20. Kellermeyer R. W., Breckenridge R. T. The inflammatory process in acute gouty arthritis. II. The presence of Hageman factor and plasma thromboplastin antecedent in synovial fluid. J Lab Clin Med. 1966 Mar;67(3):455–460. [PubMed] [Google Scholar]
  21. Kincaid-Smith P., Laver M. C., Fairley K. F. Dipyridamole and anticoagulants in renal disease due to glomerular and vascular lesions. A new approach to therapy. Med J Aust. 1970 Jan 24;1(4):145–151. [PubMed] [Google Scholar]
  22. Kniker W. T., Cochrane C. G. The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces. J Exp Med. 1968 Jan 1;127(1):119–136. doi: 10.1084/jem.127.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. LEPOW I. H., RATNOFF O. D., LEVY L. R. Studies on the activation of a proesterase associated with partially purified first component of human complement. J Exp Med. 1958 Mar 1;107(3):451–474. doi: 10.1084/jem.107.3.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. LEWIS G. P. PLASMA KININS AND OTHER VASOACTIVE COMPOUNDS IN ACUTE INFLAMMATION. Ann N Y Acad Sci. 1964 Aug 27;116:847–854. doi: 10.1111/j.1749-6632.1964.tb52550.x. [DOI] [PubMed] [Google Scholar]
  25. MACFARLANE R. G. AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER. Nature. 1964 May 2;202:498–499. doi: 10.1038/202498a0. [DOI] [PubMed] [Google Scholar]
  26. MARGOLIS J. Hagerman factor and capillary permeability. Aust J Exp Biol Med Sci. 1959 Jun;37:239–244. doi: 10.1038/icb.1959.24. [DOI] [PubMed] [Google Scholar]
  27. McKAY D. G., SHAPIRO S. S. Alterations in the blood coagulation system induced by bacterial endotoxin. I. In vivo (generalized Shwartzman reaction). J Exp Med. 1958 Mar 1;107(3):353–367. doi: 10.1084/jem.107.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. McKAY D. G., SHAPIRO S. S., SHANBERGE J. N. Alterations in the blood coagulation system induced by bacterial endotoxins. II. In vitro. J Exp Med. 1958 Mar 1;107(3):369–376. doi: 10.1084/jem.107.3.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Melmon K. L., Cline M. J. Kinins. Am J Med. 1967 Aug;43(2):153–160. doi: 10.1016/0002-9343(67)90159-3. [DOI] [PubMed] [Google Scholar]
  30. Müller-Eberhard H. J. Complement. Annu Rev Biochem. 1969;38:389–414. doi: 10.1146/annurev.bi.38.070169.002133. [DOI] [PubMed] [Google Scholar]
  31. RATNOFF O. D., DAVIE E. W. The purification of activated Hageman factor (activated factor XII). Biochemistry. 1962 Nov;1:967–975. doi: 10.1021/bi00912a005. [DOI] [PubMed] [Google Scholar]
  32. RATNOFF O. D., MILES A. A. THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR. Br J Exp Pathol. 1964 Jun;45:328–345. [PMC free article] [PubMed] [Google Scholar]
  33. STETSON C. A., Jr Studies on the mechanism of the Shwartzman phenomenon; certain factors involved in the production of the local hemorrhagic necrosis. J Exp Med. 1951 May;93(5):489–504. doi: 10.1084/jem.93.5.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Snyderman R., Shin H. S., Phillips J. K., Gewurz H., Mergenhagen S. E. A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin. J Immunol. 1969 Sep;103(3):413–422. [PubMed] [Google Scholar]
  35. Taylor F. B., Jr, Ward P. A. Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures. J Exp Med. 1967 Jul 1;126(1):149–158. doi: 10.1084/jem.126.1.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. VASSALLI P., MCCLUSKEY R. T. THE COAGULATION PROCESS AND GLOMERULAR DISEASE. Am J Med. 1965 Aug;39:179–183. doi: 10.1016/0002-9343(65)90040-9. [DOI] [PubMed] [Google Scholar]
  37. WARD P. A., COCHRANE C. G. BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS. J Exp Med. 1965 Feb 1;121:215–234. doi: 10.1084/jem.121.2.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ward P. A. A plasmin-split fragment of C'3 as a new chemotactic factor. J Exp Med. 1967 Aug 1;126(2):189–206. doi: 10.1084/jem.126.2.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Willoughby D. A., Coote E., Turk J. L. Complement in acute inflammation. J Pathol. 1969 Feb;97(2):295–305. doi: 10.1002/path.1710970215. [DOI] [PubMed] [Google Scholar]
  40. Wilner G. D., Nossel H. L., LeRoy E. C. Activation of Hageman factor by collagen. J Clin Invest. 1968 Dec;47(12):2608–2615. doi: 10.1172/JCI105943. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES